Taken together, these findings suggest that C-terminally truncated mutant ASXL1 proteins are highly expressed in leukemia cells and impair the association of wild-type ASXL1 with BAP1 in a dominant-negative manner. This evidence concerns the gene ASXL1 and leukemia.